The Dementia Symptom Management at Home Program Hospice Edition

Dementia Clinical Trial

Official title:

A Cluster Randomized Controlled Trial (RCT) of the Dementia Symptom Management (DSM) at Home Program Hospice Edition

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT03352791
• Other study ID #: 17-01080
• Status: Terminated
• Phase: N/A
• Start date: August 1, 2018
• Est. completion date: October 5, 2018

Study information

• Verified date: December 2019
• Source: NYU Langone Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare and hospice, most clinicians and agencies are ill prepared to care for this population and therefore have difficulty assisting patients and caregivers in maintaining quality of life leading to adverse patient outcomes, increased caregiver stress and burnout, and healthcare utilization. This study will utilize a cluster randomized controlled design with 6 care teams at a single study site to examine the ability of a multi-component evidence-based practice hospice care quality improvement program for registered nurses, social workers and chaplains to improve the quality of life and reduce healthcare utilization for persons with dementia and their informal caregiver.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 2
• Est. completion date: October 5, 2018
• Est. primary completion date: October 5, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• PWD over the age of 65

• Admitted to MJHS hospice agency

• The patient and family caregiver speak English and/or Spanish.

• The informal caregiver is =18 years of age and spends at least 8 hours per week with the patient.

• Patients who score =6 on the Quick Dementia Rating Scale (at least mild impairment).

Exclusion Criteria:

• Patients with a separate Axis 1 diagnosis other than forms of dementia, depression or anxiety.

• PWD residing in assisted living facilities, nursing homes or board and care homes

• PWD solely receiving infusion or home health aide services.

Related Conditions & MeSH terms

• Dementia

Intervention

Behavioral:
• DSM-H Hospice Edition performance improvement program
Patients in the performance improvement group will receive care from a care team who has received the DSM-H Hospice Edition performance improvement program
• Usual Care
control will receive usual care from a care team who has not received the performance improvement program.

Locations

Country	Name	City	State
United States	New York University School of Medicine	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reduction in pain (PAINAD)	pain assessment tool for use in persons with moderate to severe dementia who cannot provide reliable report, and will be used if the QDRS>12	Day 0 and Day 30
Primary	Reduction in Behavioral and Psychological Symptoms of Dementia (BPSD) using Neuropsychiatric Inventory Questionnaire (NPI-Q):	13-item tool that measures caregiver perception of BPSD presence and severity in PWD	Day 0 and Day 30